Botanical drugs – what is the best way forward for regulatory and market approval?
European Pharmaceutical Review
JULY 4, 2024
11 The THR pathway was created with the purpose of establishing a simplified registration procedure for all traditional herbal medicines that do not fulfil the requirements for the MA (strict) pathway under Directive 2001/83/EC. She also holds post-graduate diplomas from Oxford (IP Law) as well as King’s College (EU Competition Law).
103 
Let's personalize your content